Q86 · Healthcare · 6 measures · 3 regions
Oncology drug launches
Global: 132 in 2020–2024, +67.1% on 2015–2019.
- 132 Oncology novel active substance (NAS) launches (cumulative) · Global · 2020–2024
- +67.1% vs 2015–2019
- 6Measures
- 2Countries · 2005–2025
Verified 27 Sep 2026 · 1 publisher · 14 records
Oncology novel active substance (NAS) launches (cumulative)
The best-covered measure of oncology drug launches. Every point opens its record; the values are one click away under the chart.
Oncology novel active substance (NAS) launches (cumulative) by region
2 of 3 regions drawn, 2005–2024 to 2020–2024; every region is ranked below
No figure published for these periods
Oncology novel active substance (NAS) launches (cumulative) by region
Latest value per region, 2020–2024
View the underlying data
| Category | Source | Type | Value |
|---|---|---|---|
| Global | IQVIA | Actual | 132 |
| United States | IQVIA | Actual | 85 |
| China | IQVIA | Actual | 84 |
Every measure of oncology drug launches
6 measures: the same subject cut by product, segment, basis or form. Each has its own page with every record.
| Measure | Latest | Where and when | Records |
|---|---|---|---|
| Oncology novel active substance (NAS) launches (cumulative) | 132 | Global, 2020–2024 | 6 |
| Oncology novel active substance (NAS) launches (annual) | 25 | Global, 2024 | 3 |
| Novel active substance launches, five-year total | 388 | Global, 2021–2025 | 2 |
| Domestic-only oncology NAS launches (cumulative) | 45 | China, 2020–2024 | 1 |
| Novel active substance launches, five-year total (excluding COVID-19 products) | 369 | Global, 2021–2025 | 1 |
| Novel active substances launched exclusively in China | 30 | China, 2025 | 1 |
Oncology drug launches by country
A page for every country with at least three records:
Frequently asked questions
What does oncology drug launches measure?
Total number of novel active substances launched on the market.
What is the latest oncology novel active substance (NAS) launches (cumulative)?
Global: 132 in 2020–2024, +67.1% on 2015–2019.
Which countries does this oncology drug launches data cover?
2 countries, with a page each for China.
Where does the data come from?
From 3 documents published by IQVIA. Every figure links to its record, which quotes the sentence or table row it was read from.
How often is it updated?
Irregularly, as the publishers release new figures.
Sources
3 documents from 1 publisher. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Global Oncology Trends 2025 | IQVIA | — | 10 |
| Global R&D Trends 2026 | IQVIA | — | 3 |
| Global R&D Trends 2026 | IQVIA | — | 1 |
Cite this page
Published under CC BY 4.0: free to reuse, including commercially, with attribution to StatOrigin and the original publisher. To cite one figure, open its record.
StatOrigin. (2026). Oncology drug launches statistics [Data set]. Retrieved September 29, 2026, from https://statorigin.org/statistics/oncology-drug-launches
"Oncology drug launches statistics." StatOrigin, 2026, https://statorigin.org/statistics/oncology-drug-launches. Accessed 29 Sep. 2026.
StatOrigin. "Oncology drug launches statistics." Data set, 2026. Accessed September 29, 2026. https://statorigin.org/statistics/oncology-drug-launches.
@misc{statorigin_oncology_drug_launches_2026, title = {Oncology drug launches statistics}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/statistics/oncology-drug-launches}, note = {Data set. Accessed 2026-09-29} }